[1]孙鑫,杨克虎主编.循证医学[M].第2版:北京:人民卫生出版社,2021.
[2]朱政,胡雁,周英凤,等.构建数据化和可信的证据生态系统:首届全球循证高峰论坛报道[J].中国循证医学杂志,2017,17(12):1378-1380.
[3]Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation[J]. Int J Evid Based Healthc,2015,13(3):179-87.
[4]黄崇斐,拜争刚,吴淑婷,等.定性系统评价的撰写方法介绍[J].中国循证医学杂志,2015,15(9):1106-1111.
[5]田金徽,Fujian Song,杨克虎,等.单个病例数据Meta分析的起源与发展[J].中国药物评价,2019,36(4):241-244,263.
[6]田金徽,杨克虎,Fujian Song,等.单个病例数据Meta分析研究现状[J].中国药物评价,2019,36(4):245-251.
[7]Mullen B, Muellerleile P, Bryant B. Cumulative Meta-analysis: a consideration of indicators of sufficiency and stability[J].Pers Soc Psychol Bull,2001,27:1450-1462.
[8]许建国,郑卿勇,程露颖,等.动态系统评价的起源与发展[J].中国药物评价,2021,38(6):465-470.
[9]Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. Introduction-the why, what, when, and how[J].J Clin Epidemiol, 2017,91:23-30.
[10]Watt A, Cameron A, Sturm L, et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment[J].Int J Technol Assess Health Care, 2008, 24:133-139.
[11]Ganann R, Ciliska D, Thomas H. Expediting systematic reviews: methods and implications of rapid reviews[J].Implement Sci,2010,5:56.
[12]田金徽,陈耀龙,杨克虎,Song Fu-jian.SR/MA研究进展与挑战[J].兰州大学学报(医学版),2016,42(01):42-47.
[13]田金徽,李伦主编.网状Meta分析方法与实践[M].北京,中国医药科技出版社,2017.
[14]田金徽,陈杰峰主编.诊断试验系统评价Meta分析指导手册[M].北京,中国医药科技出版社,2015.
[15]Jansen JP. Network Meta-analysis of individual and aggregate level data[J].Res Synth Methods,2012,3(2):14.
[16]田金徽,Fujian Song,高亚,等.单个病例数据网状Meta分析的起源与发展[J].中国药物评价,2020,37(3):161-164.
[17]Vandvik PO, Brignardello-Petersen R, Guyatt GH. Living cumulative network Meta-analysis to reduce waste in research: A paradigmatic shift for systematic reviews?[J]. BMC medicine, 2016, 14: 59.
[18]许建国,高亚,孙凤,等.网络Meta分析研究进展系列(十四):动态网络Meta分析简介[J].中国循证心血管医学杂志,2021,13(7):769-772,787.
[19]高亚,孙凤,武珊珊,等.网络Meta分析研究进展系列(五):诊断试验准确性网络Meta分析[J].中国循证心血管医学杂志,2020,12(10):1161-1165.
[20]吴景玲,葛龙,张俊华,等.多个诊断性试验准确性的比较:网状Meta分析方法介绍[J].中国循证医学杂志,2017,17(8):987-992.
[21]李伦,武珊珊,杨智荣,等.网络Meta分析研究进展系列(十一):观察性研究网络Meta分析[J].中国循证心血管医学杂志,2021,13(4):385-389.
[22]张珺,李伦,刘爱萍,等.观察性研究网状Meta分析统计分析方法简介[J].中国药物评价,2016,33(6):461-463.
[23]张天嵩,董圣杰,杨智荣,等.网络Meta分析研究进展系列(十三):生存数据的网络Meta分析[J].中国循证心血管医学杂志,2021,13(6):649-652.
[24]李伦,葛龙,刘爱萍,等.如何利用WinBUGS软件开展生存数据网状Meta分析[J].中国药物评价,2016,33(5):402-405,411.
[25]李倩茹,邱霞,葛龙,等.如何撰写动物实验网状Meta分析[J].中国药物评价,2016,33(04):193-196.
[26]孙凤,杨智荣,张天嵩,等.网络Meta分析研究进展系列之一:概述[J].中国循证心血管医学杂志,2020,12(6):644-650.
[27]Hunt H, Pollock A, Campbell P, et al. An introduction to overviews of reviews: planning a relevant research question and objective for an overview[J].Syst Rev,2018,7(1):39.
[28]田金徽.系统评价再评价撰写注意事项[J].中国药物评价,2019,36(1):1-4.
[29]Papatheodorou S. Umbrella reviews:what they are and why we need them[J]. Eur J Epidemiol, 2019, 34(6): 543-546.
[30]刘海霞,胡德华,尹怀琼.伞形评价——一种新型循证医学分析方法[J].中华流行病学杂志,2020(2):261-262-263-264-265-266.
[31]Mentis AA, Dardiotis E, Efthymiou V, et al. Non-genetic risk and protective factors and biomarkers for neurological disorders: a Meta-umbrella systematic review of umbrella reviews[J].BMC Med,2021,19(1):6.
[32]Arango C, Dragioti E, Solmi M, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas[J]. World Psychiatry,2021,20(3):417-436.
[33]张迁,王琪,后亮瑛,等.动态指南制订方法及案例介绍[J].中国循证医学杂志,2021,21(4):491-496.
[34]Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews: 4. Living guideline recommendations[J].J Clin Epidemiol,2017,91:47-53.
[35]陈耀龙,张先卓,王玲,等.突发公共卫生事件下快速建议指南的制订[J].中国循证医学杂志,2020,20(5):504-510.
[36]Florez ID, Morgan RL, Falavigna M, et al. Development of rapid guidelines: 2. A qualitative study with WHO guideline developers[J].Health Res Policy Syst,2018,16(1):62.
[37]O′Rourke B, Oortwijn W, Schuller T. The new definition of health technology assessment: A milestone in international collaboration[J]. Int J Technol Assess Health Care,2020:1-4.
[38]杨珂璐,葛龙,刘明,等.GRADE在卫生技术评估中的应用[J].中国药物评价,2020,37(6):411-416.
[39]Colquhoun HL, Levac D, O′Brien KK, et al. Scoping reviews: time for clarity in definition, methods, and reporting[J].J Clin Epidemiol,2014,67(12):1291-4.
[40]高亚,葛龙,李伦,等.Scoping Review撰写方法简介[J].中国药物评价,2018,35(5):321-324.
[41]李沐阳,张福利,蔡润津,等.证据图研究现状分析[J].中国药物评价,2019,36(3):161-164.
[42]Miake-Lye IM,Hempel S,Shanman R,et al.What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products[J].Syst Rev,2016,5:28.
|